Who Decides How AI Enters Pathology? - Summary - MDSpire

Who Decides How AI Enters Pathology?

Liron Pantanowitz explains why validation, leadership, and real-world use matter more than performance metrics

  • By

  • Jessica Allerton

  • June 12, 2026

  • 6 min

Share

Objective:

Revise to connect more directly to the source material.

Key Findings:
  • Add emphasis on the need for validation in real-world settings.
Interpretation:

Focus on specific aspects from the source regarding collaboration and ethical considerations.

Limitations:
  • Explicitly mention the need for diverse datasets.
Conclusion:

Revise to reflect a cautious approach to AI integration.

Original Source(s)

Who Decides How AI Enters Pathology?

  • by Jessica Allerton

  • June 12, 2026

Related Content

A prediction model and risk stratification tool for survival by chemotherapy in invasive micropapillary carcinoma of the breast: a population-based study with external validation

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

India, and its Diagnostic Influence

Kunal Sharma explains how digital pathology, genomics, and integrated diagnostics are reshaping cancer care across India and beyond